ONECUT2 Acts as a Lineage Plasticity Driver in Adenocarcinoma as Well as Neuroendocrine Variants of Prostate Cancer

Investigators demonstrated that ONECUT2 activated resistance through multiple drivers associated with adenocarcinoma, stem-like, and neuroendocrine variants.